Blood

Vol. 146, Issue Supplement 1 Issue Supplement 1 2025
8248
Articles

Articles in this Issue

Evaluation of psychosocial impact of myelodysplastic syndromes evaluation by self report

Tito Mendoza, Rebecca Alexander, Anita Stokes et al. Nov 03, 2025 pp. 8166-8166 10.1182/blood-2025-8166

Abstract Myelodysplastic syndromes (MDS) are stem cell malignancies with diverse clinical presentations and variable prognoses. Patient-repo...

ML-driven analysis of iscn karyotypes enables detection of novel prognostic markers in chronic lymphocytic leukemia (CLL)

Ilaria Looser, Anna Stengel, Isolde Summerer et al. Nov 03, 2025 pp. 6118-6118 10.1182/blood-2025-6118

Abstract Background: Karyotyping by chromosome banding analysis (CBA) is standard-of-care in hematological malignancies...

The impact of Duffy genotype on progression-free survival (PFS) with lenalidomide, Bortezomib, and dexamethasone (RVd) alone or RVd plus autologous stem cell transplantation (ASCT) and continuous R maintenance in patients (pts) with newly diagnosed multiple myeloma (NDMM): Updated subgroup analysis of the phase 3 DETERMINATION trial

Lauren Merz, Rebecca Zon, Susanna Jacobus et al. Nov 03, 2025 pp. 1033-1033 10.1182/blood-2025-1033

Abstract Background: A single nucleotide polymorphism (SNP) in ACKR1/DARC results in erythrocyte Duffy null phenotype in ~66% of African Ame...

Real-world evaluation of health care resource utilization, clinical effectiveness, and safety of lisocabtagene maraleucel and axicabtagene ciloleucel administered in the outpatient (OP) setting for R/R large B-cell lymphoma (LBCL)

Sagar Patel, Elise Chong, Farah Toron et al. Nov 03, 2025 pp. 6270-6270 10.1182/blood-2025-6270

Abstract Introduction: Use of CD19-directed CAR T cell therapies has transformed treatment of patients with LBCL. OP administration has the...

Key factors for the success of autologous hematopoietic stem cell transplantation in HIV-infected patients with lymphoproliferative diseases

Galina Dudina, Malika Bidzhieva, Ekaterina Matveeva et al. Nov 03, 2025 pp. 7231-7231 10.1182/blood-2025-7231

Abstract Introduction: Modern antiretroviral therapy (ART) has increased the life expectancy of HIV patients, but 9% of the 40.1 million inf...

Mutational landscape of adult xanthogranuloma

Muhammad Azeem Khan, Karen Rech, Dongni Yi et al. Nov 03, 2025 pp. 7339-7339 10.1182/blood-2025-7339

Abstract Background Adult xanthogranuloma (AXG) is a rare clonal histiocytic neoplasm (HN) with a poorly defined mutatio...

High complicated incidence of Gilbert's syndrome in patients with thalassemia: Deserve earlier identification and less oversight

Tianyi Lai, Yaonan Hong, Peicheng Wang et al. Nov 03, 2025 pp. 2913-2913 10.1182/blood-2025-2913

Abstract Thalassemia comprises a group of inherited disorders characterized by impaired synthesis of globin chains, leading to increased ery...

The clinical utility of COMET™ sequential immunofluorescence in lymphoma tissue diagnostics: Next generation diagnosis.

Matthew Pugh, Gary Reynolds, Stefan Dojcinov Nov 03, 2025 pp. 4339-4339 10.1182/blood-2025-4339

Abstract Background: Immunohistochemistry is essential to the pathological diagnosis of formalin-fixed paraffin-embedded (FFPE) tissue biops...

Risk factors for cytokine release syndrome and neurotoxicity in patients receiving epcoritamab or glofitamab for large B cell lymphoma: A multi-center, retrospective, real world analysis.

Xi Yang, Yasmin Karimi, Xiaoying Chen et al. Nov 03, 2025 pp. 401-401 10.1182/blood-2025-401

Abstract Introduction: CD20xCD3 bispecific antibodies (BsAb) have been approved for use in relapsed/refractory (RR) large B-Cell lymphomas (...

Impact of vitamin d deficiency on quality of life and clinical outcomes in patients with multiple myeloma

Kawita Kitichotkul, Piangrawee Niprapan, Nonthakorn Hantrakun et al. Nov 03, 2025 pp. 4571-4571 10.1182/blood-2025-4571

Abstract Background: Multiple myeloma (MM) is a plasma cell malignancy with multi-organ involvement, including renal impairment, anemia, and...

Molecular profile linked to resistance to hypomethilating agents plus venetoclax does not predict outcome in secondary Acute Myeloid Leukemia patients receiving CPX-351 induction.

Carola Riva, Paola Minetto, Giada Zecchetti et al. Nov 03, 2025 pp. 3402-3402 10.1182/blood-2025-3402

Abstract Introduction Acute Myeloid Leukemia (AML) is a heterogeneous disease, driven by the serial acquisition of somatic mutations, that ma...

Number of cardiac deaths associated with ibrutinib versus zanubrutinib for the treatment of chronic lymphocytic leukemia: A European risk-based estimation

Talha Munir, Paolo Sportoletti, Andrea Visentin et al. Nov 03, 2025 pp. 8033-8033 10.1182/blood-2025-8033

Abstract Introduction Bruton tyrosine kinase inhibitors include ibrutinib (first generation) and zanubrutinib (next-generation) are approved...

It's that time of the month: Menstrual suppression among adolescents and young adults with cancer and quality of life

Rebekah Proctor, Edward Winter, Christina Croney et al. Nov 03, 2025 pp. 2692-2692 10.1182/blood-2025-2692

Abstract Introduction: Adolescents and young adults (AYAs) with cancer have significantly worse health related quality of life (HRQL) than t...

Zanubrutinib is well tolerated and effective in acalabrutinib-intolerant patients with B-cell malignancies: A long-term follow-up

Mazyar Shadman, Ian Flinn, Moshe Levy et al. Nov 03, 2025 pp. 5663-5663 10.1182/blood-2025-5663

Abstract Introduction: While Bruton tyrosine kinase (BTK) inhibitors are a mainstay of treatment for B-cell malignancies, their use can be l...

Interim results from a multicenter trial assessing the clinical relevance of copy number aberrations detected by a shallow whole-genome sequencing analysis (LeukoPrint) in multiple myeloma.

Li Gao, Liping Su, Fengyan Jin et al. Nov 03, 2025 pp. 3982-3982 10.1182/blood-2025-3982

Abstract Introduction Multiple myeloma (MM) is a malignancy of clonal plasma cells, accounting for 10% of hematologic malignancies. Both prim...

Young (35 years) matched sibling donors for allogeneic transplantation with post-transplantation cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: A study from the ALWP/EBMT

Arnon Nagler, Allain Thibeault Ferhat, Yener Koc et al. Nov 03, 2025 pp. 4193-4193 10.1182/blood-2025-4193

Abstract Background: Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative therapeutic option for secondary acute myeloid...

Parkinsonism and other non-immune effector cell-associated neurotoxicities related to BCMA-directed chimeric antigen receptor T-cell therapy

Paul Worsley, Jianzheng Wu, Isuru Ratnayake et al. Nov 03, 2025 pp. 2389-2389 10.1182/blood-2025-2389

Abstract Background: In the setting of relapsed/refractory (R/R) multiple myeloma (MM), B-cell maturation antigen (BCMA) directed chimeric a...

Indoleamine 2,3-dioxygenase 1 (IDO1) promotes immune effector cell-associated neurotoxicity syndrome (ICANS) after CAR-T therapy by disrupting brain endothelial cell integrity via KYNU–AA–Wnt/β-catenin pathway

Wanying Zhang, Zhaozhao Chen, Liman Su et al. Nov 03, 2025 pp. 807-807 10.1182/blood-2025-807

Abstract Background: Elevated serum tryptophan levels are observed in patients with immune effector cell-associated neurotoxicity syndrome (...

Usefulness of C5b9 deposition analysis for the diagnosis, treatment, and monitoring of patients with transplant-associated thrombotic microangiopathy

Julia Martinez-Sanchez, Candela Ceballos, Nerea Arratibel et al. Nov 03, 2025 pp. 4210-4210 10.1182/blood-2025-4210

Abstract Background: Transplant-associated thrombotic microangiopathy (TA-TMA) is a life-threatening complication of allogeneic hematopoieti...

Disparities in palliative care consultation among hospitalized patients with diffuse large B-cell lymphoma in the United States: A national analysis from 2016–2022

Alexandra Sueldo, Youjin Oh, Lucas Kuzmanic et al. Nov 03, 2025 pp. 1899-1899 10.1182/blood-2025-1899

Abstract Background: Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma and often requires intensive t...

Evaluating targeted long-read sequencing as a diagnostic tool for burkitt lymphoma

Giuliano Banco, Kostiantyn Dreval, Laura Hilton et al. Nov 03, 2025 pp. 3547-3547 10.1182/blood-2025-3547

Abstract Introduction: While sporadic in developed countries, Burkitt lymphoma (BL) is endemic in resource-limited regions. Given the one-ye...

Longitudinal analysis of richter syndrome risk and survival in CLL: The role of targeted therapy and molecular markers. experience at the fondazione policlinico gemelli in rome.

Idanna Innocenti, Tommaso Quaranta, Francesco Iadevaia et al. Nov 03, 2025 pp. 5679-5679 10.1182/blood-2025-5679

Abstract Background: Richter Syndrome (RS) is the development of an aggressive lymphoma in patients (pts) with chronic lymphocytic leukemia...

Lymphovision: A lymphoma-specialized foundation model for histology-based lymphoma classification and subtyping

Jansen Seheult, Wenchao Han, Reyhan Keser et al. Nov 03, 2025 pp. 117-117 10.1182/blood-2025-117

Abstract Background: Recent advances in computer vision have given rise to image foundation models (FMs), large-scale neural networks pre-tr...

Iron-deficiency anemia in premenopausal women: A comparative study of menstrual blood loss and malabsorptive etiologies

Farah Mohamed Ramzy Hasan Mohamed, Enis Bora Kavak, Rayso Abdallah Abdillahi et al. Nov 03, 2025 pp. 6471-6471 10.1182/blood-2025-6471

Abstract Introduction Intestinal iron malabsorption refers to the impaired uptake of dietary iron across the gastrointes...

Real-world outcomes with blinatumomab as a bridging therapy for allogeneic hematopoietic stem cell transplantation in relapsed/refractory or measurable residual disease-positive B-cell acute lymphoblastic leukemia: A CIBMTR database analysis

Wael Saber, Ruta Brazauskas, Jinalben Patel et al. Nov 03, 2025 pp. 6044-6044 10.1182/blood-2025-6044

Abstract Background: Blinatumomab has been used as an effective therapy for the treatment of adult and pediatric patients in various setting...

All Issues

Journal Info

Publisher Elsevier BV
ISSN 0006-4971
E-ISSN 1528-0020
Subject Health Sciences
Language English
View Full Journal Page